Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / PRVL - ALERT: Halper Sadeh LLP Investigates RP MDCA TCF PRVL; Shareholders Are Encouraged to Contact the Firm


PRVL - ALERT: Halper Sadeh LLP Investigates RP MDCA TCF PRVL; Shareholders Are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / January 5, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

RealPage, Inc. (NASDAQ:RP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Thoma Bravo for $88.75 in cash per share. If you are a RealPage shareholder, click here to learn more about your rights and options.

MDC Partners Inc. (NASDAQ:MDCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Stagwell Media LP. Stagwell and its affiliates are expected to hold approximately 79% of the common equity of the combined company after closing. If you are an MDC shareholder, click here to learn more about your rights and options.

TCF Financial Corporation (NASDAQ:TCF) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Huntington Bancshares Incorporated. Under the merger, TCF shareholders will reportedly receive 3.0028 Huntington shares for each TCF share. If you are a TCF shareholder, click here to learn more about your rights and options.

Prevail Therapeutics Inc. (NASDAQ:PRVL) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Eli Lilly and Company. Under the terms of the merger agreement, Prevail shareholders will receive $22.50 per share in cash plus one non-tradable contingent value right worth up to $4.00 per share in cash. If you are a Prevail shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/623129/ALERT-Halper-Sadeh-LLP-Investigates-RP-MDCA-TCF-PRVL-Shareholders-Are-Encouraged-to-Contact-the-Firm

Stock Information

Company Name: Prevail Therapeutics Inc.
Stock Symbol: PRVL
Market: NYSE
Website: prevailtherapeutics.com

Menu

PRVL PRVL Quote PRVL Short PRVL News PRVL Articles PRVL Message Board
Get PRVL Alerts

News, Short Squeeze, Breakout and More Instantly...